Cukier Herm 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed May 10, 2019
Insider Transaction Report
Form 4
Cukier Herm
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2019-05-08$5.07/sh−29,425$149,185→ 37,421 total - Exercise/Conversion
Common Stock
2019-05-08+66,666→ 66,666 total - Sale
Common Stock
2019-05-09$4.92/sh−860$4,231→ 36,381 total - Exercise/Conversion
Restricted Stock Units
2019-05-08+66,666→ 133,334 totalExp: 2021-05-08→ Common Stock (66,666 underlying)
Footnotes (3)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 66,666 Performance Restricted Stock Units ("PRSUs") granted to the Reporting Person on May 2, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended , subject to certain performance measures. The remainder of the PRSUs under this grant will vest: i) one-half after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures and ii) the remaining half after the first open window upon the filing of the Company's Annual Report in March 2021 subject to certain performance measures. The PRSUs convert into common stock on a one-for-one basis.
- [F2]The shares of Common Stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of PRSUs.
- [F3]On May 8, 2019, the Reporting Person sold an aggregate of 29,425 shares of the Common Stock at a weighted average price of $5.07 per share. The highest sale price for the Common Stock was $5.19 per share and the lowest sale price was $4.99 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in these footnotes.